In summary, we have established a new WM and DLBCL cell line model that mimics the effect of the MYD88L265P mutation in combination with a loss of the TNFAIP3 gene and A20 expression. The gene discussed is TNFAIP3; the disease is diffuse large B-cell lymphoma.